The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function

Neurology

Volumn 58, Issue 8, 2002, Pages 1175-1181

  Posner, H B ^b,c   Tang, M X ^b,c   Luchsinger, J ^c   Lantigua, R ^a,c   Stern, Y ^a,b,c   Mayeux, R ^a,b,c  

^a Columbia University ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; DEPTH PERCEPTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HEART DISEASE; HUMAN; HYPERTENSION; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEMORY; MULTIINFARCT DEMENTIA; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RISK FACTOR; STROKE; TASK PERFORMANCE;

EID: 0037161304     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.8.1175     Document Type: Article

References (50)

1. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study
2. Midlife blood pressure and dementia: The Honolulu-Asia aging study
3. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia
4. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: The HAAS. Honolulu-Asia aging Study
5. Risk factors for vascular dementia: A review
6. 15-Year longitudinal study of blood pressure and dementia
7. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study
8. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?
9. Hypertension
10. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
11. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics
12. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician
13. FAS test
14. Evaluating storage, retention, and retrieval in disordered memory and learning
15. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education
16. Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis
17. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
18. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
19. A new clinical scale for the staging of dementia
20. Experience from a multicentre stroke register: A preliminary report
21. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study
22. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
23. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks
24. Models for longitudinal data: A generalized estimating equation approach
25. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective
26. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study
27. Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men
28. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
29. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
30. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
31. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program
32. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults
33. Dementia and disability outcomes in large hypertension trials: Lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) trial
34. Benefits of antihypertensive drug treatment in elderly patients with isolated systolic hypertension
35. Vascular dementia. Incidence and risk factors in the Canadian Study of Health and Aging
36. Diabetes mellitus and the risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort
37. Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys
38. Cognitive performance in hypertensive and normotensive older subjects
39. Longterm predictors of cognitive outcome in a cohort of older people with hypertension
40. Blood pressure and cognitive function in healthy old people
41. Relation of blood pressure to cognitive function in the elderly